Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the ...

Prepare for an epic food journey as I explore Las Vegas's largest buffet: the famous Bacchanal Buffet inside Caesars Palace! Today, I’m diving into their brand-new Crab Brunch, packed with endless ...

Twelve years after launching the successful Maple Street Biscuit Co. chain, co-founder Scott Moore is set to debut a new and ...

The company said Monday that fosigotifator failed to outperform placebo in slowing the neurodegenerative disease, but is ...

A fierce bird attacked a calico cat lurking under its tree territory. Footage shows the oriental magpie robin swooping down ...

STAT reporters discuss why a looming patent cliff could lead to more pharmaceutical deal-making and a new obesity startup.

Though Olive does not have an eye problem, she squints her eye because the “cat eye language” she was taught as a kitten came ...

In studies by Massachusetts General Hospital, the AbbVie-Calico collaborative drug and Denali Therapeutics' own drug failed to meet endpoints for treating amyotrophic lateral sclerosis, more widely ...

First, meet Ebony, a lovable 1-year-old pit bull with the kindest heart. Ebony is a gentle soul who adores attention and is sweet to everyone she meets. Whether it's a new friend or a familiar face, ...

Under the terms of the deal, Alchemab and Lilly will work together on up to five new antibodies, according to a Jan. 9 ...

AbbVie, Calico and Denali Therapeutics’ hopes of treating amyotrophic lateral sclerosis (ALS) by targeting eIF2B have all ...

Analyst Justin Post of Bank of America Securities maintained a Buy rating on Alphabet Class A (GOOGL – Research Report), retaining the price ...